Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines. It is engaged in clinical development programs in cystic fibrosis and other conditions such as sickle cell disease, beta thalassemia, alpha-1 antitrypsin deficiency, APOL1-mediated kidney disease, duchenne muscular dystrophy, type 1 diabetes, and acute and chronic pain.